<div id="readability-page-1"><p>Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 2,000 shares of the business's stock in a transaction dated Thursday, December 26th. The stock was sold at an average price of $63.01, for a total value of $126,020.00. Following the transaction, the chief executive officer now directly owns 42,497 shares of the company's stock, valued at approximately $2,677,735.97. This represents a 4.49 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.</p><div><p><span></span><span>Get <strong>Kewaunee Scientific</strong> alerts:</span></p></div><h2>Kewaunee Scientific Stock Up 0.4 %</h2><ul><li>3 Hot Micro-Caps On EPS Watch</li></ul><p>KEQU stock traded up $0.23 during trading on Friday, hitting $63.85. 28,625 shares of the company's stock were exchanged, compared to its average volume of 17,455. The business has a 50-day moving average price of $41.99 and a two-hundred day moving average price of $43.12. The company has a current ratio of 2.53, a quick ratio of 2.00 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $183.25 million, a price-to-earnings ratio of 10.12 and a beta of 0.80. Kewaunee Scientific Co. has a 52-week low of $27.00 and a 52-week high of $66.15. </p><h2>Institutional Inflows and Outflows</h2><p>Several large investors have recently modified their holdings of the stock. JPMorgan Chase &amp; Co. raised its stake in  Kewaunee Scientific by 18,000.0% during the 3rd quarter. JPMorgan Chase &amp; Co. now owns 905 shares of the technology company's stock worth $30,000 after acquiring an additional 900 shares in the last quarter.  Geode Capital Management LLC lifted its holdings in shares of  Kewaunee Scientific by 8.9% in the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company's stock valued at $792,000 after purchasing an additional 1,941 shares during the last quarter.  Ritholtz Wealth Management boosted its position in shares of  Kewaunee Scientific by 24.6% in the 3rd quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company's stock valued at $363,000 after purchasing an additional 2,156 shares during the period.  Barclays PLC purchased a new position in  Kewaunee Scientific during the 3rd quarter worth approximately $121,000.  Finally, Heron Bay Capital Management acquired a new position in  Kewaunee Scientific during the second quarter worth approximately $252,000. Institutional investors and hedge funds own  32.69% of the company's stock. </p><h2>Analysts Set New Price Targets</h2><p>Separately, StockNews.com raised Kewaunee Scientific from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Wednesday, December 18th.</p><p><b>View Our Latest Stock Report on Kewaunee Scientific</b></p><h2>Kewaunee Scientific Company Profile</h2> (Get Free Report)<p>Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Kewaunee Scientific</li><li>Are Penny Stocks a Good Fit for Your Portfolio?</li><li>S&amp;P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains</li><li>3 Small Caps With Big Return Potential</li><li>How AI Implementation Could Help MongoDB Roar Back in 2025</li><li>Stock Market Sectors: What Are They and How Many Are There? </li><li>Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><p>→ We recommended Palantir in 2021, now we’re recommending this... <span><span>(From Behind the Markets)</span> <span>(Ad)</span></span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDg0MQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDg0MQ"/></p><h2>Should you invest $1,000 in Kewaunee Scientific right now?</h2><p>Before you consider Kewaunee Scientific, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.</p><p>While Kewaunee Scientific currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

KEQU

<p>Kewaunee Scientific Co. CEO Thomas David Hull III sold 2,000 shares of the company's stock at an average price of $63.01, totaling $126,020. Following the sale, he owns 42,497 shares, a 4.49% decrease in his position. The transaction was disclosed to the SEC. Kewaunee's stock recently traded at $63.85, with a market cap of $183.25 million and a P/E ratio of 10.12. Analysts have upgraded the stock from "hold" to "buy."</p>

Thomas David Hull III Sells 2,000 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) Stock